☆ 4.6 Article

High-Dose Pemetrexed in Combination with High-Dose Crizotinib for the Treatment of Refractory CNS Metastases in ALK-Rearranged Non-Small-Cell Lung Cancer

JOURNAL OF THORACIC ONCOLOGY (2013)

Get Full Text
Add to Collection

Journal

JOURNAL OF THORACIC ONCOLOGY
Volume 8, Issue 1, Pages E3-E5

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1097/JTO.0b013e3182762d20

Keywords

-

Categories

Oncology Respiratory System

Funding

  1. Pfizer
  2. Genentech
  3. GSK
  4. Celgene

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.